Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 December 2005

J Med Genet. Published Online First: 16 March 2005. doi:10.1136/jmg.2005.030791
Copyright © 2005 by the BMJ Publishing Group Ltd.

Review article

MONOGENIC SYNDROMES OF ABNORMAL GLUCOSE HOMEOSTASIS: CLINICAL REVIEW AND RELEVANCE TO THE UNDERSTANDING OF THE PATHOLOGY OF INSULIN RESISTANCE AND {beta} CELL FAILURE

John R Porter 1* and Timothy G Barrett 2

1 Birmingham Children's Hospital, United Kingdom
2 University of Birmingham, United Kingdom

* To whom correspondence should be addressed. E-mail: j.porter{at}bham.ac.uk.

Accepted 11 March 2005


Abstract

Type 2 diabetes mellitus is one of the major health issues worldwide in this century, and is caused by a combination of insulin resistance and beta cell failure. The polygenic nature of type 2 diabetes has made it difficult to study, and although many candidate genes for type 2 diabetes have been suggested, in most cases association studies have been equivocal. Monogenic forms of diabetes have been studied extensively in the last ten years, and the genetic basis of many of these syndromes has been elucidated, leading to greater understanding of the functions of the genes involved in these diabetes syndromes. Common variations in the genes causing monogenic disorders have been associated with susceptibility to type 2 diabetes in several populations, and explain some of the linkage seen in genome wide scans. Monogenic disorders are also increasingly helpful in highlighting and increasing our knowledge of both normal and disordered glucose and insulin metabolism. Three main areas of defect contributing to diabetes are found; defects in insulin signalling leading to insulin resistance; defects of insulin secretion leading to hypoinsulinaemia; and apoptosis leading to decreased beta cell mass. This article presents a review of these three pathological pathways illustrated by rare genetic syndromes, which have diabetes as a prominent feature. Apoptosis in particular seems to be a final common pathway in both type 1 and type 2 diabetes, and here study of rare forms of diabetes may allow us to recognise new therapeutic targets to preserve or increase {beta}cell mass and function.

Keywords: Apoptosis, Diabetes, Genetic, Insulin, Monogenic


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Sookoian, S., Pirola, C. J. (2007). Review: Genetics of the cardiometabolic syndrome: new insights and therapeutic implications. Ther Adv Cardiovasc Dis 1: 37-47 [Abstract]  
  • Yamada, T., Ishihara, H., Tamura, A., Takahashi, R., Yamaguchi, S., Takei, D., Tokita, A., Satake, C., Tashiro, F., Katagiri, H., Aburatani, H., Miyazaki, J.-i., Oka, Y. (2006). WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic {beta}-cells. Hum Mol Genet 15: 1600-1609 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Genetics jobs

Genetics jobs